Statistics

Total Visits

Views
Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial 900

Total Visits per Month

February 2025 March 2025 April 2025 May 2025 June 2025 July 2025 August 2025
Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial 29 33 22 34 29 24 6

File Downloads

Views
Kyriazopoulou.pdf 347

Top Country Views

Views

Top City Views

Views